These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16491742)

  • 21. Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarction.
    Gum PA; Lincoff AM
    Int J Clin Pract; 2003; 57(1):43-8. PubMed ID: 12587942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of primary angioplasty in nonagenarians with acute myocardial infarction.
    Danzi GB; Centola M; Pomidossi GA; Consonni D; De Matteis S; Stabile A; Sesana M; Anzuini A; Sganzerla P; Cortese B; Migliorini A; Antoniucci D
    Am J Cardiol; 2010 Sep; 106(6):770-3. PubMed ID: 20816115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rescue angioplasty after thrombolysis.
    Sharma S; Bhambi B; Nyitray W
    N Engl J Med; 2006 Apr; 354(15):1639-41; author reply 1639-41. PubMed ID: 16615182
    [No Abstract]   [Full Text] [Related]  

  • 24. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
    Popma JJ; Satler LF
    J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does abciximab provide long-term benefit for patients with acute myocardial infarction treated with stents?
    Neumann FJ
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):190-1. PubMed ID: 16568126
    [No Abstract]   [Full Text] [Related]  

  • 26. Stenting and abciximab in primary angioplasty: a review of current status.
    De Luca G; Suryapranata H; Piscione F; Barbato E; Chiariello M
    Ital Heart J; 2005 Nov; 6(11):874-80. PubMed ID: 16320920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry.
    Rakowski T; Siudak Z; Dziewierz A; Birkemeyer R; Legutko J; Mielecki W; Depukat R; Janzon M; Stefaniak J; Zmudka K; Dubiel JS; Partyka L; Dudek D
    Am Heart J; 2009 Oct; 158(4):569-75. PubMed ID: 19781416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary percutaneous coronary intervention.
    Kapoor R; Kapoor JR
    N Engl J Med; 2008 Jan; 358(4):431; author reply 432-3. PubMed ID: 18216369
    [No Abstract]   [Full Text] [Related]  

  • 29. [MULTISTRATEGY and FATA: merits, limits and troubles of no profit clinical trials in acute myocardial infarction].
    Savonitto S
    G Ital Cardiol (Rome); 2009 Jun; 10(6):364-5. PubMed ID: 19603607
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials.
    Navarese EP; Kozinski M; Obonska K; Margheri M; Gurbel PA; Kubica J; De Luca G
    Platelets; 2012; 23(4):274-81. PubMed ID: 21988317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The early management of ST-elevation acute myocardial infarction in the Lombardy Region (GestIMA)].
    Oltrona L; Mafrici A; Marzegalli M; Fiorentini C; Pirola R; Vincenti A;
    Ital Heart J Suppl; 2005 Aug; 6(8):489-97. PubMed ID: 16161503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
    Mehta SR;
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.
    Singh S; Gopal AK; Bahl VK
    Indian Heart J; 2005; 57(3):201-9. PubMed ID: 16196176
    [No Abstract]   [Full Text] [Related]  

  • 35. Facilitated PCI: crossing the bridge with lessons learned.
    Mishra S; Bahl VK
    Indian Heart J; 2009; 61(5):410-2. PubMed ID: 20635753
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects on mortality of abciximab in ST-elevation myocardial infarction treated with percutaneous coronary intervention including stent implantation.
    Tornvall P; Nilsson T; Lagerqvist B
    J Intern Med; 2006 Oct; 260(4):363-8. PubMed ID: 16961673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No reflow and the quest to achieve optimal perfusion during the acute phase of myocardial infarction.
    Chaitman BR; Lim MJ
    J Am Coll Cardiol; 2004 Jul; 44(2):313-5. PubMed ID: 15261924
    [No Abstract]   [Full Text] [Related]  

  • 38. Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes: Gusto IV-ACS.
    Cohen M
    Lancet; 2001 Jun; 357(9272):1899-900. PubMed ID: 11425405
    [No Abstract]   [Full Text] [Related]  

  • 39. [Primary coronary angioplasty for myocardial infarction--the view of the cardiologic surgeon].
    Tabone X
    Ann Cardiol Angeiol (Paris); 2012 Nov; 61(5):352-6. PubMed ID: 23098611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.
    Eur Heart J; 1996 Jan; 17(1):43-63. PubMed ID: 8682130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.